Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous

References

• Herrada AA, Escobedo N, Iruretagoyena M, et al. Innate immune cells’ contribution to systemic lupus erythematosus. Front Immunol. 2019;10:772.
   PubMed Web of Science ®Google Scholar
• Anders H, Saxena R, Zhao M, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6:7.
   PubMed Web of Science ®Google Scholar
• Hur K, Kim SH, Kim JM. Potential implications of long noncoding RNAs in autoimmune diseases. Immune Netw. 2019;19:e4. eCollection 2019 Feb.
   PubMed Web of Science ®Google Scholar
• Zhao CN, Mao YM, Liu LN, et al. Emerging role of lncRNAs in systemic lupus erythematosus. Biomed Pharmacother. 2018;106:584–592.
   PubMed Web of Science ®Google Scholar
• Yang F, He Y, Zhai Z, et al. Programmed cell death pathways in the pathogenesis of systemic lupus erythematosus. J Immunol Res. 2019;2019:3638562. eCollection.
   PubMed Web of Science ®Google Scholar
• Sayad A, Hajifathali A, Hamidieh AA, et al. Fas-Antisense long noncoding RNA and Acute Myeloid Leukemia: is there any relation? Asian Pac J Cancer Prev. 2018;19:45–48.
   PubMedGoogle Scholar
• Colombo T, Farina L, Macino G, et al. PVT1: a rising star among Oncogenic long noncoding RNAs. Biomed Res Int. 2015;304208. DOI:10.1155/2015/304208.
   PubMed Web of Science ®Google Scholar
• Du P, Hu C, Qin Y, et al. LncRNA PVT1 mediates Antiapoptosis and 5-Fluorouracil resistance via increasing Bcl2 expression in Gastric Cancer. J Oncol. 2019;2019:1–10. Article ID 9325407.
   Web of Science ®Google Scholar
• Zhou Q, Chen F, Zhao J, et al. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195. Oncotarget. 2016;7:82620–82633.
   PubMedGoogle Scholar
• Li Z, Li X, Jiang C, et al. Long non-coding RNAs in rheumatoid arthritis. Cell Prolif. 2018;51:e12404.
   PubMed Web of Science ®Google Scholar
• Eftekharian MM, Ghafouri-Fard SSoudyab M, et al. Expression analysis of long non-coding rnas in the blood of multiple sclerosis patients. Mol Neurosci. 2017;63:333–341.
   PubMed Web of Science ®Google Scholar
• Sandhya P, Joshi K, Scaria V. Long noncoding RNAs could be potential key players in the pathophysiology of Sjogren’s syndrome. Int J Rheum Dis. 2015;18:898–905.
   PubMed Web of Science ®Google Scholar
• Waller P, Blann AD. Non-coding RNAs - A primer for the laboratory scientist. Br J Biomed Sci. 2019;76:157–165.
   PubMed Web of Science ®Google Scholar
• Wu GC, Li J, Leng RX, et al. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus. Oncotarget. 2017;8:23650–23663.
   PubMedGoogle Scholar
• Aringer M, Costenbader K, Daikh D, et al. European league against Rheumatism/American College of Rheumatology classification criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400–1412.
   PubMed Web of Science ®Google Scholar
• Castrejón I, Tani C, Jolly M, et al. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol. 2014;32:85–95.
   PubMed Web of Science ®Google Scholar
• Shaker OG, Ali MA, Ahmed TI, et al. Association between LINC00657 and miR-106a serum expression levels and susceptibility to colorectal cancer, adenomatous polyposis, and ulcerative colitis in Egyptian population. IUBMB Life. 2019;71:1322–1335.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Wang T, Liu Y, et al. LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis. Oncotarget. 2017;8:75455–75466.
   PubMedGoogle Scholar
• Sehgal L, Mathur R, Braun FK, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28:2376–2387.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao J, Guo X, et al. Long non-coding RNA PVT1, a molecular sponge for miR-149, contributes aberrant metabolic dysfunction and inflammation in IL-1β-simulated osteoarthritic chondrocytes. Biosci Rep. pii 2018;38:BSR20180576.
   PubMed Web of Science ®Google Scholar
• Huang W, Lan X, Li X, et al. Long non-coding RNA PVT1 promote LPS-induced septic acute kidney injury by regulating TNFα and JNK/NF-κB pathways in HK-2 cells. Int Immunopharmacol. 2017;47:134–140.
   PubMed Web of Science ®Google Scholar
• Tahernia L, Namazi S, Rezaei N, et al. Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities. Rheumatol Res. 2017;2:1–9.
   Google Scholar
• Sarhan RA, Aboelenein HR, Sourour SK, et al. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients. Discov Med. 2015;19:419–425.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y. The correlation of plasma microRNA-200 family expressions with risk and disease severity of lupus nephritis. Eur Rev Med Pharmacol Sci. 2018;22:3118–3125.
   PubMed Web of Science ®Google Scholar
• Liu C, Yang H, Shi W, et al. MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease. Immunology. 2018;155:427–434.
   PubMed Web of Science ®Google Scholar
• Yuliasih Y, Rahmawati LD, Putri RM. Th17/Treg ratio and disease activity in Systemic Lupus Erythematosus. Caspian J Intern Med. 2019;10:65–72.
   PubMed Web of Science ®Google Scholar
• Zhang CW, Wu X, Liu D, et al. Long non-coding RNA PVT1 knockdown suppresses fibroblast-like synoviocyte inflammation and induces apoptosis in rheumatoid arthritis through demethylation of sirt6. J Biol Eng. 2019;13:60.
   PubMed Web of Science ®Google Scholar
• Littlejohn E, Marder W, Lewis E, et al. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever. Lupus. 2018;27:1123–1129.
   PubMed Web of Science ®Google Scholar